Tag
donanemab
-
Medicare announces coverage of costly Alzheimer’s medication. That could mean high premiums for beneficiaries
Medicare coverage of new Alzheimer’s treatments will raise premiums and increase out-of-pocket costs for beneficiaries, new analysis finds.
